Karl-Walter Jauch
Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery
Kasparek M, Bruckmeier A, Beigel F, Müller M, Brand S, Mansmann U, Jauch K, Ochsenkühn T, Kreis M. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery. Inflamm Bowel Dis 2011; 18:1207-13.
Sep 16, 2011Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery
Sep 16, 2011Inflamm Bowel Dis 2011; 18:1207-13
Kasparek Michael S, Bruckmeier Andreas, Beigel Florian, Müller Mario H, Brand Stephan, Mansmann Ulrich, Jauch Karl-Walter, Ochsenkühn Thomas, Kreis Martin E
Augmenter of liver regeneration causes different kinetics of ERK1/2 and Akt/PKB phosphorylation than EGF and induces hepatocyte proliferation in an EGF receptor independent and liver specific manner
Ilowski M, Putz C, Weiss T, Brand S, Jauch K, Hengstler J, Thasler W. Augmenter of liver regeneration causes different kinetics of ERK1/2 and Akt/PKB phosphorylation than EGF and induces hepatocyte proliferation in an EGF receptor independent and liver specific manner. Biochem Biophys Res Commun 2010; 394:915-20.
Mar 15, 2010Augmenter of liver regeneration causes different kinetics of ERK1/2 and Akt/PKB phosphorylation than EGF and induces hepatocyte proliferation in an EGF receptor independent and liver specific manner
Mar 15, 2010Biochem Biophys Res Commun 2010; 394:915-20
Ilowski Maren, Putz Christine, Weiss Thomas S, Brand Stephan, Jauch Karl-Walter, Hengstler Jan G, Thasler Wolfgang Erwin